Factors contributing to tumor shrinkage after peptide receptor radionuclide therapy in patients with unresectable neuroendocrine tumors

被引：0

作者：

Noritoshi, K. ^{[1
]}

Sho, H. ^{[1
]}

Wild, D. ^{[2
]}

Kaul, F. ^{[2
]}

Motokazu, S. ^{[1
]}

Naoki, O. ^{[1
]}

Risa, F. ^{[1
]}

Akihiro, S. ^{[1
]}

Motohiko, T. ^{[1
]}

Shoko, T. ^{[1
]}

Yasushi, I ^{[1
]}

机构：

[1] Yokohama City Univ, Yokohama, Kanagawa, Japan

[2] Univ Hosp Basel, Basel, Switzerland

来源：

JOURNAL OF NEUROENDOCRINOLOGY | 2023年 / 35卷

关键词：

lesion-based analysis; neuroendocrine tumor; peptide receptor radionuclide therapy;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

H29

引用

页码：201 / 201

页数：1

共 50 条

[21] Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumor [J].

Kaemmerer, Daniel ;

Prasad, Vikas ;

Daffner, Wolfgang ;

Hoersch, Dieter ;

Kloeppel, Guenter ;

Hommann, Merten ;

Baum, Richard P. .

WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (46) :5867-5870

[22] Real-world efficacy of lutetium peptide receptor radionuclide therapy in patients with neuroendocrine tumors [J].

Almeamar, H. ;

Cullen, L. ;

Murphy, D. ;

Crowley, R. ;

Skehan, S. ;

Welin, S. ;

O'Shea, D. ;

O'Toole, D. .

JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 :136-136

[23] Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights [J].

Starr, Jason S. ;

Sonbol, Mohamad Bassam ;

Hobday, Timothy J. ;

Sharma, Akash ;

Kendi, Ayse Tuba ;

Halfdanarson, Thorvardur R. .

ONCOTARGETS AND THERAPY, 2020, 13 :3545-3555

[24] Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT) [J].

Marco Schiavo Lena ;

Stefano Partelli ;

Paola Castelli ;

Valentina Andreasi ;

Chanel Elisha Smart ;

Eleonora Pisa ;

Mirco Bartolomei ;

Emilio Bertani ;

Giuseppe Zamboni ;

Massimo Falconi ;

Claudio Doglioni .

Endocrine Pathology, 2020, 31 :119-131

[25] Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT) [J].

Schiavo Lena, Marco ;

Partelli, Stefano ;

Castelli, Paola ;

Andreasi, Valentina ;

Smart, Chanel Elisha ;

Pisa, Eleonora ;

Bartolomei, Mirco ;

Bertani, Emilio ;

Zamboni, Giuseppe ;

Falconi, Massimo ;

Doglioni, Claudio .

ENDOCRINE PATHOLOGY, 2020, 31 (02) :119-131

[26] Liver-Directed Therapy for Neuroendocrine Tumor Liver Metastases in the Era of Peptide Receptor Radionuclide Therapy [J].

Lehrman, Evan D. ;

Fidelman, Nicholas .

SEMINARS IN INTERVENTIONAL RADIOLOGY, 2020, 37 (05) :499-507

[27] Somatostatin receptor radionuclide therapy in neuroendocrine tumors [J].

Haider, Mintallah ;

Das, Satya ;

Al-Toubah, Taymeyah ;

Pelle, Eleonora ;

El-Haddad, Ghassan ;

Strosberg, Jonathan .

[28] A Care Process Model to Deliver 177Lu-Dotatate Peptide Receptor Radionuclide Therapy for Patients With Neuroendocrine Tumors [J].

Kasi, Pashtoon Murtaza ;

Maige, Catherine L. ;

Shahjehan, Faisal ;

Rodgers, Jessica M. ;

Aloszka, Debora L. ;

Ritter, Ashton ;

Andrus, Margaret L. ;

Mcmillan, Jessica M. ;

Mody, Kabir ;

Sharma, Akash ;

Jain, Manoj K. .

FRONTIERS IN ONCOLOGY, 2019, 8

[29] Partial Response Upon Peptide Receptor Radionuclide Therapy in a Highly Proliferative Pancreatic Neuroendocrine Tumor [J].

Weich, Alexander ;

Serfling, Sebastian E. ;

Rowe, Steven P. ;

Solnes, Lilja B. ;

Buck, Andreas K. ;

Higuchi, Takahiro ;

Werner, Rudolf A. .

CLINICAL NUCLEAR MEDICINE, 2023, 48 (06) :547-548

[30] Safety and Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) Following Bland Embolization for Metastatic Neuroendocrine Tumors [J].

Alayli, Adam ;

Ngo, Hoang ;

Sikaria, Dhiraj ;

Ahmed, Altan ;

Salloum, Elias ;

Strosberg, Jonathan R. ;

Al-Toubah, Taymeyah E. ;

Kis, Bela ;

Haider, Mintallah ;

El-Haddad, Ghassan .

CANCERS, 2024, 16 (15)

← 1 2 3 4 5 →